User:Mikezchen

Min Chiu Li

Dr. Min Chiu Li (Min-Chiu Li, 李敏求; September 21, 1919 – February 12, 1980) was a Chinese-born American physician and cancer researcher. He was born in Deqing (德庆), Guangdong (广东) province, China. After graduated from Mukden Medical College (Shenyang Medical College, now China Medical University, 中国医科大学) in Shenyang (沈阳), Liaoning (辽宁) province, Dr. Li moved to the USA in 1947. He studied bacteriology and immunology at the Post Graduate School of Medicine of the University of Southern California. In 1952, Dr. Li worked as a resident in medicine at the Presbyterian Hospital in Chicago. He then worked at the Sloan-Kettering Institute in 1953. In August 1955, he moved to the National Cancer institute, worked in the Endocrinology Branch under Dr. Hertz. He moved back to the Sloan-Kettering Institute in 1957. He severed as director of Medical Research and Oncology, Nassau Hospital (now Winthrop-University Hospital) from 1963 to 1976. He worked as director of Cancer Center, Scripps Memorial Hospital La Jolla, California from 1976 to 1980.

He worked as Chairman of the National Cancer Research Committee of the National Science Council of the Taiwan, Republic of China in 1975.

AWARDS: Alfred Sloan Award, 1957 Albert Lasker Award for Clinical Research, 1972

Clinical Research Achievements (Freireich, 2002): “With his 1956 report of 3 cases of choriocarcinoma responding to methotrexate, Dr. M. C. Li became the first therapeutic scientist to demonstrate that systemic chemotherapy could result in the cure of metastatic malignant disease. He recognized the value of tumor markers by measuring chorionic gonadotropin levels in blood during and after use of methotrexate in treating choriocarcinoma. In 1960, Dr. Li published another important and original finding, the use of multiple agent combination chemotherapy for metastatic testicular cancer. Combined with techniques for local control, this has virtually eliminated testicular malignancy as a major cause of mortality in men. In 1977, Dr. Li reported the effect of 5-fluorouracil given as an adjuvant after colon surgery in improving long term survival. This led to intensive re-investigation of the question of adjuvant treatment for this disease.”

Reference: Freireich, E.J., Min Chiu Li: A perspective in Cancer Therapy, Clinical Cancer Research, 2764-2765, 9, 2002.

--Mikezchen (talk) 16:32, 29 June 2008 (UTC)